Improving Transplant Medication Safety Through a Technology and Pharmacist Intervention (ISTEP): Protocol for a Cluster Randomized Controlled Trial

• DOI: 10.2196/13821
• Publication Date: 2019-05-31T22:06:45Z
• Authors: Casey L Hall; Cory E Fominaya; Mulugeta Gebregzi...; Sherry K Milfred-...; Kelsey M Rife; David J Taber
• Keywords: 03 medical and health sciences; 0302 clinical medicine; Protocol; 3. Good health

Medication errors, adverse drug events, and nonadherence lead to increased health care utilization risk of clinical outcomes, including graft loss, in solid organ transplant recipients. Veterans living with transplants represent a population that is at substantial for medication safety events fragmented coordination issues. To improve long-term outcomes veteran patients, interventions should address interorganizational system failures provider-level patient-level factors.This study aims measure the economic effectiveness pharmacist-led, technology-enabled intervention, compared usual care, recipients.This 24-month prospective, parallel-arm, cluster-randomized, controlled multicenter study. The pharmacist-led intervention uses an innovative dashboard posttransplant care. Pharmacists 10 sites will be consented into this before undergoing randomization, 5 then randomized each arm. Approximately, 1600 patients included assessment primary outcome across sites.This ongoing. Institutional review board approval was received October 2018 opened March 2019. date there are no findings from study, as delivery scheduled occur over period. first results expected submitted publication August 2021.With report, we describe design, methods, measures used ongoing trial. Successful completion Improving Transplant Safety through Technology Pharmacist Intervention provide empirical evidence feasible scalable on improving costs.ClinicalTrials.gov NCT03860818; https://clinicaltrials.gov/ct2/show/NCT03860818.PRR1-10.2196/13821.